Skip to content

Spanner Temporary Prostatic Stent

by Srs Medical

PMA P060010

Active United States

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

PMA P060010↗

FDA record

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA PMA, synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA PMAAPPR Approved NumberP060010 Date14 Dec 2006ApprovedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

PMA

Full name
The Spanner Temporary Prostatic Stent
Generic Name
Stent, urethral, prostatic, semi-permanent
PMA Number
FDA Product Code
NZC
Device Class
Class III
Advisory Committee
Gastroenterology, Urology
FDA Decision
APPR Approved

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Spanner Temporary Prostatic Stent is a semi-permanent urethral stent designed to maintain urine flow and facilitate voluntary urination in patients. It is intended for temporary use (up to 30 days) following minimally invasive treatment for benign prostatic hyperplasia (BPH) and after initial post-treatment catheterization.

This device is supplied sterile and intended for single-use. It is classified as a Class III medical device under FDA regulations and requires a Premarket Approval (PMA) application. The Spanner Temporary Prostatic Stent is regulated under PMA number P060010 and falls under the product code NZC for urethral stents.

Other devices from Srs Medical

  • CT3000Pro

    Class II

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Spanner Temporary Prostatic Stent primarily used for in clinical practice?

    The Spanner Temporary Prostatic Stent is designed to maintain urine flow and enable voluntary urination in patients temporarily, specifically after minimally invasive treatments for benign prostatic hyperplasia (BPH) or following initial post-treatment catheterization. It is intended for short-term use (up to 30 days) to support recovery and reduce reliance on catheters during this period.

  • Is the Spanner Temporary Prostatic Stent meant for long-term use, or is it strictly temporary?

    The Spanner Temporary Prostatic Stent is explicitly intended for temporary use only, with a maximum duration of 30 days. Its design and regulatory approval reflect this limited-time application, ensuring it supports recovery without prolonged implantation.

  • How is the Spanner Temporary Prostatic Stent supplied, and is it reusable?

    The Spanner Temporary Prostatic Stent is supplied sterile and is intended for single-use only. This ensures patient safety and hygiene, as reuse could introduce infection risks or compromise device integrity.

  • What regulatory pathway does the Spanner Temporary Prostatic Stent follow, and how does that affect its availability?

    The Spanner Temporary Prostatic Stent requires Premarket Approval (PMA) under FDA regulations, with approval granted via PMA number P060010. This classification (Class III) means it undergoes rigorous review by the FDA’s Gastroenterology and Urology advisory committee before being authorized for use, ensuring its safety and effectiveness for the specified temporary application.